Covestor’s HCA Healthcare HCA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$77K Sell
198
-7
-3% -$2.96K 0.04% 516
2026
Q1
$97K Sell
205
-188
-48% -$94.6K 0.07% 301
2025
Q4
$184K Sell
393
-54
-12% -$25.1K 0.1% 257
2025
Q3
$191K Buy
447
+13
+3% +$5.04K 0.11% 232
2025
Q2
$166K Sell
434
-88
-17% -$31.7K 0.1% 268
2025
Q1
$180K Buy
522
+92
+21% +$29.6K 0.12% 190
2024
Q4
$129K Sell
430
-551
-56% -$193K 0.08% 362
2024
Q3
$399K Buy
981
+401
+69% +$147K 0.25% 35
2024
Q2
$187K Buy
580
+86
+17% +$27.9K 0.12% 177
2024
Q1
$165K Sell
494
-462
-48% -$141K 0.1% 240
2023
Q4
$259K Buy
956
+504
+112% +$125K 0.18% 69
2023
Q3
$111K Sell
452
-508
-53% -$139K 0.08% 351
2023
Q2
$291K Sell
960
-60
-6% -$16.7K 0.22% 48
2023
Q1
$269K Buy
1,020
+84
+9% +$21.3K 0.23% 51
2022
Q4
$224K Sell
936
-19
-2% -$4.25K 0.18% 83
2022
Q3
$176K Buy
955
+794
+493% +$158K 0.16% 104
2022
Q2
$27K Sell
161
-6
-4% -$1.29K 0.02% 920
2022
Q1
$42K Buy
167
+92
+123% +$23.1K 0.03% 853
2021
Q4
$19K Buy
+75
New +$18.4K 0.03% 869

Other funds holding HCA

Covestor's HCA Position: Q2 2026 in Review

Covestor reduced its HCA Healthcare (HCA) stake by 3.4% in Q2 2026, selling an estimated $2.96K and leaving 198 shares worth $77K. The position accounts for 0.04% of the portfolio, ranked #516.

Covestor first reported a position in HCA in Q4 2021 and has held it in 19 quarters since. The position peaked at $399K in Q3 2024. 1,333 funds tracked by Wall St. Rank hold HCA as of Q2 2026.

  • Covestor held 198 shares of HCA Healthcare worth $77K as of Q2 2026.
  • Covestor sold 7 HCA Healthcare shares in Q2 2026, an estimated $2.96K.
  • HCA Healthcare made up 0.04% of Covestor's portfolio in Q2 2026, its #516 holding.
  • Covestor first reported a position in HCA Healthcare in Q4 2021 and has held it in 19 quarters since.
  • Covestor's HCA Healthcare position peaked at $399K in Q3 2024.
  • 1,333 funds tracked by Wall St. Rank held HCA Healthcare as of Q2 2026.

Based on Covestor's 13F filing for Q2 2026, filed 7 Aug 2026.